Article Listing - King Pharmaceuticals 2nd-qtr earnings leap 77%

EC PHARMA MARKET FORECASTS TO 1996

27 April 1992

The European Community pharmaceutical market is expected to continue growing over the next five years at a rate in excess...

GOOD 1991 FOR FRANCE'S JOUVEINAL

27 April 1992

With 1991 turnover of 946 million francs ($168.8 million), French pharmaceutical comp-any Jouveinal witnessed an 8% improvement on the previous...

MEIJI MILK PRODS TEST-MARKETING PREGNANCY TEST

27 April 1992

Meiji Milk Products of Japan has begun test-marketing a pregnancy test which is produced by Ortho Pharmaceutical Corp of the...

NEUTOGENA ACQUIRES INTEREST IN CELLEGY

27 April 1992

Neutrogena Corp has acquired a minority interest in Cellegy Pharmaceuticals, a dermatological products R&D company. Full terms of the agreement...

CONTROVERSIAL ALLERGY THERAPIES

27 April 1992

A report from the UK Royal College of Physicians concludes that many of the claims made for the efficacy of...

CAPOTEN CUTS MORTALITY IN SAVE

27 April 1992

Bristol-Myers Squibb's angiotensin converting enzyme inhibitor product Capoten (captopril) reduces mortality by 17% in post-myocardial infarct patients without overt heart...

STOCK MARKET COMMENTARY: TOKYO

27 April 1992

TOKYO: stocks were thinly traded last week, as foreign investors packed up for the Easter holiday, but the Nikkei Average...

STOCK MARKET COMMENTARY: NEW YORK

27 April 1992

NEW YORK: experienced a triple-witching hour ahead of the Easter weekend, which pushed the Dow Jones to a new high,...

Mexico Import Regulations

27 April 1992

The Mexican Ministry of Health has announced intensification of control measures to avoid the illegal entry of medi-cines from foreign...

JAPAN'S PROJECTED 1992 MEDICAL COSTS

27 April 1992

An increase of 6.9% to 23,170 billion yen ($172.62 billion) is expected in Japan's medical costs for the current year,...

Showing 94161-94170 of 95365 articles